Smith Group Asset Management, LLC Corcept Therapeutics Inc Transaction History
Smith Group Asset Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Smith Group Asset Management, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Smith Group Asset Management, LLC holds 15,256 shares of CORT stock, worth $877,830. This represents 0.06% of its overall portfolio holdings.
Number of Shares
15,256
Previous 12,175
25.31%
Holding current value
$877,830
Previous $396 Million
78.49%
% of portfolio
0.06%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding CORT
# of Institutions
347Shares Held
86.6MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$952 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$576 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$476 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$375 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$219 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $6.16B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...